402 related articles for article (PubMed ID: 11268288)
1. CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice.
Xu L; Daly T; Gao C; Flotte TR; Song S; Byrne BJ; Sands MS; Parker Ponder K
Hum Gene Ther; 2001 Mar; 12(5):563-73. PubMed ID: 11268288
[TBL] [Abstract][Full Text] [Related]
2. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
3. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
4. Functions of AAV-CMV-F.IX And AAV-EF1alpha-F.IX in gene therapy for hemophilia B.
Wiwanitkit V
Hum Gene Ther; 2007 Feb; 18(2):89-92. PubMed ID: 17266422
[TBL] [Abstract][Full Text] [Related]
5. A CMV-actin-globin hybrid promoter improves adeno-associated viral vector gene expression in the arterial wall in vivo.
Nitta Y; Kawamoto S; Halbert C; Iwata A; Miller AD; Miyazaki J; Allen MD
J Gene Med; 2005 Oct; 7(10):1348-55. PubMed ID: 15945122
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic levels of factor IX expression using a muscle-specific promoter and adeno-associated virus serotype 1 vector.
Liu YL; Mingozzi F; Rodriguéz-Colôn SM; Joseph S; Dobrzynski E; Suzuki T; High KA; Herzog RW
Hum Gene Ther; 2004 Aug; 15(8):783-92. PubMed ID: 15319035
[TBL] [Abstract][Full Text] [Related]
7. Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter.
Hagstrom JN; Couto LB; Scallan C; Burton M; McCleland ML; Fields PA; Arruda VR; Herzog RW; High KA
Blood; 2000 Apr; 95(8):2536-42. PubMed ID: 10753832
[TBL] [Abstract][Full Text] [Related]
8. Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors.
Song S; Embury J; Laipis PJ; Berns KI; Crawford JM; Flotte TR
Gene Ther; 2001 Sep; 8(17):1299-306. PubMed ID: 11571566
[TBL] [Abstract][Full Text] [Related]
9. Efficient gene transfer into mouse embryonic stem cells with adenovirus vectors.
Kawabata K; Sakurai F; Yamaguchi T; Hayakawa T; Mizuguchi H
Mol Ther; 2005 Sep; 12(3):547-54. PubMed ID: 15950541
[TBL] [Abstract][Full Text] [Related]
10. Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter.
Xie X; Zhao X; Liu Y; Young CY; Tindall DJ; Slawin KM; Spencer DM
Hum Gene Ther; 2001 Mar; 12(5):549-61. PubMed ID: 11268287
[TBL] [Abstract][Full Text] [Related]
11. Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver.
Wang L; Nichols TC; Read MS; Bellinger DA; Verma IM
Mol Ther; 2000 Feb; 1(2):154-8. PubMed ID: 10933925
[TBL] [Abstract][Full Text] [Related]
12. In utero lung gene transfer using adeno-associated viral and lentiviral vectors in mice.
Joyeux L; Danzer E; Limberis MP; Zoltick PW; Radu A; Flake AW; Davey MG
Hum Gene Ther Methods; 2014 Jun; 25(3):197-205. PubMed ID: 24660751
[TBL] [Abstract][Full Text] [Related]
13. JSRV Intragenic Enhancer Element Increases Expression from a Heterologous Promoter and Promotes High Level AAV-mediated Transgene Expression in the Lung and Liver of Mice.
Yu DL; Chow N; Wootton SK
Viruses; 2020 Nov; 12(11):. PubMed ID: 33172105
[TBL] [Abstract][Full Text] [Related]
14. Targeting transgene to the heart and liver with AAV9 by different promoters.
Chen BD; He CH; Chen XC; Pan S; Liu F; Ma X; Li XM; Gai MT; Tao J; Ma YT; Yang YN; Gao XM
Clin Exp Pharmacol Physiol; 2015 Oct; 42(10):1108-17. PubMed ID: 26173818
[TBL] [Abstract][Full Text] [Related]
15. Enhanced transgene expression in the mouse skeletal muscle infected by the adeno-associated viral vector with the human elongation factor 1alpha promoter and a human chromatin insulator.
Mori-Uchino M; Takeuchi T; Murakami I; Yano T; Yasugi T; Taketani Y; Nakagawa K; Kanda T
J Gene Med; 2009 Jul; 11(7):598-604. PubMed ID: 19399759
[TBL] [Abstract][Full Text] [Related]
16. Liver-restricted expression of the canine factor VIII gene facilitates prevention of inhibitor formation in factor VIII-deficient mice.
Ishiwata A; Mimuro J; Mizukami H; Kashiwakura Y; Takano K; Ohmori T; Madoiwa S; Ozawa K; Sakata Y
J Gene Med; 2009 Nov; 11(11):1020-9. PubMed ID: 19757487
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Adeno-Associated Viral Vector-Mediated Human Factor VIII Gene Therapy in Hemophilia A Mice.
Greig JA; Wang Q; Reicherter AL; Chen SJ; Hanlon AL; Tipper CH; Clark KR; Wadsworth S; Wang L; Wilson JM
Hum Gene Ther; 2017 May; 28(5):392-402. PubMed ID: 28056565
[TBL] [Abstract][Full Text] [Related]
18. Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver.
Nakai H; Herzog RW; Hagstrom JN; Walter J; Kung SH; Yang EY; Tai SJ; Iwaki Y; Kurtzman GJ; Fisher KJ; Colosi P; Couto LB; High KA
Blood; 1998 Jun; 91(12):4600-7. PubMed ID: 9616156
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus.
Teschendorf C; Warrington KH; Siemann DW; Muzyczka N
Anticancer Res; 2002; 22(6A):3325-30. PubMed ID: 12530082
[TBL] [Abstract][Full Text] [Related]
20. A small regulatory element from chromosome 19 enhances liver-specific gene expression.
Li C; Hirsch M; Carter P; Asokan A; Zhou X; Wu Z; Samulski RJ
Gene Ther; 2009 Jan; 16(1):43-51. PubMed ID: 18701910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
